About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Scripps MD Anderson Cancer Center
https://www.Scripps.org/HemOncCME
Clinical Hematology & Oncology 2024
Melanoma 2024: 34th Annual Cutaneous Malignancy Update
2023 Cancer Care Symposium
2023 Oncology Update
Clinical Hematology & Oncology 2023
Melanoma 2023: 33rd Annual Cutaneous Malignancy Update
2022 Cancer Care Symposium
Clinical Hematology & Oncology 2022
Melanoma 2022: 32nd Annual Cutaneous Malignancy Update
2021 Cancer Care Symposium
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020
Nonmalignant Hematology
Malignant Hematology
Updates in Oncology
Breast Cancer Updates
Event Info
Eighth Annual Scripps Cancer Care Symposium
Melanoma 2020: 30th Annual Cutaneous Malignancy Update
Diagnosis and Management of Melanoma
Cases
Event Info
7th Annual Scripps Cancer Care Symposium
Survivorship and Palliative Care
Cancer and Cardiovascular Disease
Immunotherapy
Ethics, Genetics and Society
Debates
Event info
2019 Oncology Update
2019 Oncology Update Videos
Event info
Melanoma 2019: 29th Annual Cutaneous Malignancy Update
Melanoma 2019: 29th Annual Cutaneous Malignancy Update Videos
Event Info
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
Malignant Hematology
Nonmalignant Hematology
Updates in Oncology
Topics in Cancer
Event Info
Videos
Events
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
Frontline Treatment Options for Hodgkin's Lymphoma: Response-Adapted Approaches Using PET/CT & Review of Brentuximab Vedotin Trials
By
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
FEATURING
Jakub Svoboda
By
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
FEATURING
Jakub Svoboda
215 views
July 4, 2019
0 Comments
Login to view comments.
Click here to Login
Featured Video
15:14
Icahn School of Medicine at Mount Sinai
Safety Profile of Ruxolitinib in Patients With MF
Feat.
D. Tremblay
Featured Video
06:51
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…
Feat.
D. Tremblay
Malignant Hematology
13:11
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
Waldenstrom's Macroglobulinemia - Novel Agents in Initial Treat…
Feat.
A. Mahindra
26:26
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
Novel Treatment Options for AL & ATTR Amyloidosis
Feat.
A. Mahindra
17:11
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
First Line Treatment for CLL - Ibrutinib Plus Obinutuzumab, Ibrutini…
Feat.
W. Wierda
13:01
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
Future Standard of Care Regimens in CLL: Ibrutinib + Venetoclax Comb…
Feat.
W. Wierda
09:20
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
Treatment for Relapsed/Refractory CLL - Updates from MURANO Trial (V…
Feat.
W. Wierda
10:01
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
Primary CNS Lymphoma - Clinical Features & Staging, Pretreatment…
Feat.
C. Grommes
13:27
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
Treatment of Primary CNS Lymphoma: Upfront Regimen, Surgery, Treatme…
Feat.
C. Grommes
13:57
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
Targeted Therapies in CNS Lymphoma & Salvage Options per NCCN Gu…
Feat.
C. Grommes
09:16
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
AML and CD33 Targeted Therapy - Results from Gemtuzumab Ozogamicin T…
Feat.
A. Perl
08:56
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
Novel Treatment Options for High-Risk/Eldery AML Patients: CPX-351, …
Feat.
A. Perl
18:23
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
Targeting FLT3 mutations in AML: Daunorubicin, Midostaurin, Sorafeni…
Feat.
A. Perl
06:37
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
Targeting IDH Inhibitors in AML with Enasidenib and Ivosidenib
Feat.
A. Perl
32:01
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
Frontline Treatment Options for Hodgkin's Lymphoma: Response-Ad…
Feat.
J. Svoboda
15:22
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
Relapsed/Refractory Hodgkin Lymphoma - Salvage Treatments, Nivolumab…
Feat.
J. Svoboda
22:03
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
Frontline Strategy for Aggressive Lymphoma - Can we Replace RCHOP?
Feat.
J. Westin
23:24
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
Treatment of Relapsed Aggressive Lymphoma - Evaluating CAR T Trials
Feat.
J. Westin
09:49
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
Overview of Diagnosis and Prognosis in Pediatric vs. Adult ALL
Feat.
H. Kantarjian
16:17
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
Pediatric Inspired Regimens in Adult ALL: Is Combination Therapy Bet…
Feat.
H. Kantarjian
21:08
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
MRD-Positive ALL Treatment Options in 2019: Antibody Cocktail Regime…
Feat.
H. Kantarjian
